Selodenoson

DB16325InvestigationalSmall molecule

Selodenoson is under investigation in clinical trial NCT00040001 (Safety and Efficacy Study of an A1-adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation).

Mechanism: Pharmacologically active on Adenosine receptor A1
Curator reviewed
Formula / weight: C₁₇H₂₄N₆O₄ · 376.417 g/mol (avg)
Code names: DTI-0009 · GR-56072 · RG-14202

Resolves to

Compound

UNII103G5E953KCAS110299-05-3ChEMBLCHEMBL2107371

Structure

InChIKeyGWVQGVCXFNYGFP-PFHKOEEOSA-NSMILESCCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2NC1CCCC1

Targets

P30542ADORA1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Selodenoson, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account